Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study.

Day MJ, Hopkins KL, Wareham DW, Toleman MA, Elviss N, Randall L, Teale C, Cleary P, Wiuff C, Doumith M, Ellington MJ, Woodford N, Livermore DM.

Lancet Infect Dis. 2019 Dec;19(12):1325-1335. doi: 10.1016/S1473-3099(19)30273-7. Epub 2019 Oct 22.

2.

Human carriage of cefotaxime-resistant Escherichia coli in North-East India: an analysis of STs and associated resistance mechanisms.

Paul D, Babenko D, Toleman MA.

J Antimicrob Chemother. 2020 Jan 1;75(1):72-76. doi: 10.1093/jac/dkz416.

PMID:
31622465
3.

Dissemination of genetically diverse NDM-1, -5, -7 producing-Gram-negative pathogens isolated from pediatric patients in Pakistan.

Qamar MU, Walsh TR, Toleman MA, Tyrrell JM, Saleem S, Aboklaish A, Jahan S.

Future Microbiol. 2019 May;14:691-704. doi: 10.2217/fmb-2019-0012. Epub 2019 May 31.

PMID:
31148474
4.

Prospective genomic surveillance of methicillin-resistant Staphylococcus aureus (MRSA) associated with bloodstream infection, England, 1 October 2012 to 30 September 2013.

Toleman MS, Reuter S, Jamrozy D, Wilson HJ, Blane B, Harrison EM, Coll F, Hope RJ, Kearns A, Parkhill J, Peacock SJ, Török ME.

Euro Surveill. 2019 Jan;24(4). doi: 10.2807/1560-7917.ES.2019.24.4.1800215.

5.

OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coli.

Livermore DM, Day M, Cleary P, Hopkins KL, Toleman MA, Wareham DW, Wiuff C, Doumith M, Woodford N.

J Antimicrob Chemother. 2019 Feb 1;74(2):326-333. doi: 10.1093/jac/dky453.

PMID:
30388219
6.

First identification of clinical isolate of a Novel "NDM-4" producing Escherichia coli ST405 from urine sample in Pakistan.

Qamar MU, Walsh TR, Toleman MA, Saleem S, Jahan S.

Braz J Microbiol. 2018 Oct - Dec;49(4):949-950. doi: 10.1016/j.bjm.2018.02.009. Epub 2018 Apr 12. No abstract available.

7.

Analysis of Escherichia coli STs and resistance mechanisms in sewage from Islamabad, Pakistan indicates a difference in E. coli carriage types between South Asia and Europe.

Zahra R, Javeed S, Malala B, Babenko D, Toleman MA.

J Antimicrob Chemother. 2018 Jul 1;73(7):1781-1785. doi: 10.1093/jac/dky109.

PMID:
29648612
8.

High Prevalence of Intra-Familial Co-colonization by Extended-Spectrum Cephalosporin Resistant Enterobacteriaceae in Preschool Children and Their Parents in Dutch Households.

Liakopoulos A, van den Bunt G, Geurts Y, Bootsma MCJ, Toleman M, Ceccarelli D, van Pelt W, Mevius DJ.

Front Microbiol. 2018 Feb 21;9:293. doi: 10.3389/fmicb.2018.00293. eCollection 2018.

9.

Direct in Gel Genomic Detection of Antibiotic Resistance Genes in S1 Pulsed Field Electrophoresis Gels.

Toleman MA.

Methods Mol Biol. 2018;1736:129-136. doi: 10.1007/978-1-4939-7638-6_12.

PMID:
29322465
10.

In vitro and in vivo activity of Manuka honey against NDM-1-producing Klebsiella pneumoniae ST11.

Qamar MU, Saleem S, Toleman MA, Saqalein M, Waseem M, Nisar MA, Khurshid M, Taj Z, Jahan S.

Future Microbiol. 2018 Jan;13:13-26. doi: 10.2217/fmb-2017-0119. Epub 2017 Dec 11.

PMID:
29226698
11.

Investigation of a Cluster of Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Transmission in a Community Setting.

Toleman MS, Watkins ER, Williams T, Blane B, Sadler B, Harrison EM, Coll F, Parkhill J, Nazareth B, Brown NM, Peacock SJ.

Clin Infect Dis. 2017 Nov 29;65(12):2069-2077. doi: 10.1093/cid/cix539.

12.

Longitudinal genomic surveillance of MRSA in the UK reveals transmission patterns in hospitals and the community.

Coll F, Harrison EM, Toleman MS, Reuter S, Raven KE, Blane B, Palmer B, Kappeler ARM, Brown NM, Török ME, Parkhill J, Peacock SJ.

Sci Transl Med. 2017 Oct 25;9(413). pii: eaak9745. doi: 10.1126/scitranslmed.aak9745. Epub 2017 Oct 25.

13.

Genomic surveillance reveals low prevalence of livestock-associated methicillin-resistant Staphylococcus aureus in the East of England.

Harrison EM, Coll F, Toleman MS, Blane B, Brown NM, Török ME, Parkhill J, Peacock SJ.

Sci Rep. 2017 Aug 7;7(1):7406. doi: 10.1038/s41598-017-07662-2.

14.

Clonal differences in Staphylococcus aureus bacteraemia-associated mortality.

Recker M, Laabei M, Toleman MS, Reuter S, Saunderson RB, Blane B, Török ME, Ouadi K, Stevens E, Yokoyama M, Steventon J, Thompson L, Milne G, Bayliss S, Bacon L, Peacock SJ, Massey RC.

Nat Microbiol. 2017 Oct;2(10):1381-1388. doi: 10.1038/s41564-017-0001-x. Epub 2017 Aug 7.

15.

The Future of Peritoneal Dialysis in a Moving Landscape of Bacterial Resistance.

Toleman MA.

Perit Dial Int. 2017 Mar-Apr;37(2):134-140. doi: 10.3747/pdi.2016.00038. Review. No abstract available.

PMID:
28360364
16.

Horizontal transfer of the blaNDM-1 gene to Pseudomonas aeruginosa and Acinetobacter baumannii in biofilms.

Tanner WD, Atkinson RM, Goel RK, Toleman MA, Benson LS, Porucznik CA, VanDerslice JA.

FEMS Microbiol Lett. 2017 Apr 1;364(8). doi: 10.1093/femsle/fnx048.

PMID:
28333234
17.

First detection of extended-spectrum cephalosporin- and fluoroquinolone-resistant Escherichia coli in Australian food-producing animals.

Abraham S, Jordan D, Wong HS, Johnson JR, Toleman MA, Wakeham DL, Gordon DM, Turnidge JD, Mollinger JL, Gibson JS, Trott DJ.

J Glob Antimicrob Resist. 2015 Dec;3(4):273-277. doi: 10.1016/j.jgar.2015.08.002. Epub 2015 Sep 28.

PMID:
27842872
18.

Unconventional Human T Cells Accumulate at the Site of Infection in Response to Microbial Ligands and Induce Local Tissue Remodeling.

Liuzzi AR, Kift-Morgan A, Lopez-Anton M, Friberg IM, Zhang J, Brook AC, Roberts GW, Donovan KL, Colmont CS, Toleman MA, Bowen T, Johnson DW, Topley N, Moser B, Fraser DJ, Eberl M.

J Immunol. 2016 Sep 15;197(6):2195-207. doi: 10.4049/jimmunol.1600990. Epub 2016 Aug 15.

19.

World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal Production.

Collignon PJ, Conly JM, Andremont A, McEwen SA, Aidara-Kane A; World Health Organization Advisory Group, Bogotá Meeting on Integrated Surveillance of Antimicrobial Resistance (WHO-AGISAR), Agerso Y, Andremont A, Collignon P, Conly J, Dang Ninh T, Donado-Godoy P, Fedorka-Cray P, Fernandez H, Galas M, Irwin R, Karp B, Matar G, McDermott P, McEwen S, Mitema E, Reid-Smith R, Scott HM, Singh R, DeWaal CS, Stelling J, Toleman M, Watanabe H, Woo GJ.

Clin Infect Dis. 2016 Oct 15;63(8):1087-1093. doi: 10.1093/cid/ciw475. Epub 2016 Jul 20. Review. Erratum in: Clin Infect Dis. 2016 Dec 1;63(11):1536.

PMID:
27439526
20.

Local Persistence of Novel MRSA Lineage after Hospital Ward Outbreak, Cambridge, UK, 2011-2013.

Toleman MS, Reuter S, Coll F, Harrison EM, Peacock SJ.

Emerg Infect Dis. 2016 Sep;22(9):1658-9. doi: 10.3201/eid2209.151100. Epub 2016 Sep 15. No abstract available.

21.

Systematic Surveillance Detects Multiple Silent Introductions and Household Transmission of Methicillin-Resistant Staphylococcus aureus USA300 in the East of England.

Toleman MS, Reuter S, Coll F, Harrison EM, Blane B, Brown NM, Török ME, Parkhill J, Peacock SJ.

J Infect Dis. 2016 Aug 1;214(3):447-53. doi: 10.1093/infdis/jiw166. Epub 2016 Apr 27.

22.

Genetic & virulence profiling of ESBL-positive E. coli from nosocomial & veterinary sources.

Tyrrell JM, Wootton M, Toleman MA, Howe RA, Woodward M, Walsh TR.

Vet Microbiol. 2016 Apr 15;186:37-43. doi: 10.1016/j.vetmic.2016.02.007. Epub 2016 Feb 18.

PMID:
27016755
23.

Vaccination of chemotherapy patients--effect of guideline implementation.

Toleman MS, Herbert K, McCarthy N, Church DN.

Support Care Cancer. 2016 May;24(5):2317-2321. doi: 10.1007/s00520-015-3037-6. Epub 2015 Nov 26.

PMID:
26610767
24.

Specific PCR, bacterial culture, serology and pharyngeal sampling to enhance the aetiological diagnosis of cellulitis.

Toleman MS, Vipond IB, Brindle R.

J Med Microbiol. 2016 Jan;65(1):44-47. doi: 10.1099/jmm.0.000191.

PMID:
26487664
25.

Extensively drug-resistant New Delhi metallo-β-lactamase-encoding bacteria in the environment, Dhaka, Bangladesh, 2012.

Toleman MA, Bugert JJ, Nizam SA.

Emerg Infect Dis. 2015 Jun;21(6):1027-30. doi: 10.3201/eid2106.141578.

26.

Random insertion and gene disruption via transposon mutagenesis of Ureaplasma parvum using a mini-transposon plasmid.

Aboklaish AF, Dordet-Frisoni E, Citti C, Toleman MA, Glass JI, Spiller OB.

Int J Med Microbiol. 2014 Nov;304(8):1218-25. doi: 10.1016/j.ijmm.2014.09.003. Epub 2014 Sep 26.

27.

Characterization of plasmids in extensively drug-resistant acinetobacter strains isolated in India and Pakistan.

Jones LS, Carvalho MJ, Toleman MA, White PL, Connor TR, Mushtaq A, Weeks JL, Kumarasamy KK, Raven KE, Török ME, Peacock SJ, Howe RA, Walsh TR.

Antimicrob Agents Chemother. 2015 Feb;59(2):923-9. doi: 10.1128/AAC.03242-14. Epub 2014 Nov 24.

28.

Co-existence of blaNDM-1 and blaKPC-2 in clinical isolates of Klebsiella pneumoniae from Pakistan.

Sattar H, Toleman M, Nahid F, Zahra R.

J Chemother. 2016 Aug;28(4):346-9. doi: 10.1179/1973947814Y.0000000223. No abstract available.

PMID:
25407219
29.

Plasmid carriage of bla NDM-1 in clinical Acinetobacter baumannii isolates from India.

Jones LS, Toleman MA, Weeks JL, Howe RA, Walsh TR, Kumarasamy KK.

Antimicrob Agents Chemother. 2014 Jul;58(7):4211-3. doi: 10.1128/AAC.02500-14. Epub 2014 Apr 21.

30.

The challenge to patient safety by emerging Gram negative pathogens.

Toleman M.

J Infect Public Health. 2014 Feb;7(1):1-5. doi: 10.1016/j.jiph.2013.12.001. No abstract available.

31.

Genetic characterization and emergence of the metallo-β-lactamase GIM-1 in Pseudomonas spp. and Enterobacteriaceae during a long-term outbreak.

Wendel AF, Brodner AH, Wydra S, Ressina S, Henrich B, Pfeffer K, Toleman MA, Mackenzie CR.

Antimicrob Agents Chemother. 2013 Oct;57(10):5162-5. doi: 10.1128/AAC.00118-13. Epub 2013 Jul 22.

32.

Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study.

Edelstein MV, Skleenova EN, Shevchenko OV, D'souza JW, Tapalski DV, Azizov IS, Sukhorukova MV, Pavlukov RA, Kozlov RS, Toleman MA, Walsh TR.

Lancet Infect Dis. 2013 Oct;13(10):867-76. doi: 10.1016/S1473-3099(13)70168-3. Epub 2013 Jul 9.

PMID:
23845533
33.

Identical miniature inverted repeat transposable elements flank class 1 integrons in clinical isolates of Acinetobacter spp.

Domingues S, Toleman MA, Nielsen KM, da Silva GJ.

J Clin Microbiol. 2013 Jul;51(7):2382-4. doi: 10.1128/JCM.00692-13. Epub 2013 Apr 17.

34.

Genetic and biochemical characterization of an acquired subgroup B3 metallo-β-lactamase gene, blaAIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia.

Yong D, Toleman MA, Bell J, Ritchie B, Pratt R, Ryley H, Walsh TR.

Antimicrob Agents Chemother. 2012 Dec;56(12):6154-9. doi: 10.1128/AAC.05654-11. Epub 2012 Sep 17.

35.

Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom.

Giske CG, Fröding I, Hasan CM, Turlej-Rogacka A, Toleman M, Livermore D, Woodford N, Walsh TR.

Antimicrob Agents Chemother. 2012 May;56(5):2735-8. doi: 10.1128/AAC.06142-11. Epub 2012 Feb 21.

36.

blaNDM-1 is a chimera likely constructed in Acinetobacter baumannii.

Toleman MA, Spencer J, Jones L, Walsh TR.

Antimicrob Agents Chemother. 2012 May;56(5):2773-6. doi: 10.1128/AAC.06297-11. Epub 2012 Feb 6.

37.

Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya.

El Salabi A, Borra PS, Toleman MA, Samuelsen Ø, Walsh TR.

Antimicrob Agents Chemother. 2012 May;56(5):2241-5. doi: 10.1128/AAC.05640-11. Epub 2012 Jan 30.

38.

The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response.

Walsh TR, Toleman MA.

J Antimicrob Chemother. 2012 Jan;67(1):1-3. doi: 10.1093/jac/dkr378. Epub 2011 Oct 12.

PMID:
21994911
39.

Plasmid typing and genetic context of AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish hospital 1999-2007.

Mata C, Miró E, Alvarado A, Garcillán-Barcia MP, Toleman M, Walsh TR, de la Cruz F, Navarro F.

J Antimicrob Chemother. 2012 Jan;67(1):115-22. doi: 10.1093/jac/dkr412. Epub 2011 Oct 6.

PMID:
21980067
40.

Association of bla(DHA-1) and qnrB genes carried by broad-host-range plasmids among isolates of Enterobacteriaceae at a Spanish hospital.

Mata C, Miró E, Toleman M, Rivera MA, Walsh TR, Navarro F.

Clin Microbiol Infect. 2011 Oct;17(10):1514-7. doi: 10.1111/j.1469-0691.2011.03539.x. Epub 2011 Jul 22.

41.

Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis.

Mata C, Navarro F, Miró E, Walsh TR, Mirelis B, Toleman M.

J Antimicrob Chemother. 2011 Oct;66(10):2266-70. doi: 10.1093/jac/dkr286. Epub 2011 Jul 13.

PMID:
21752830
42.

Combinatorial events of insertion sequences and ICE in Gram-negative bacteria.

Toleman MA, Walsh TR.

FEMS Microbiol Rev. 2011 Sep;35(5):912-35. doi: 10.1111/j.1574-6976.2011.00294.x. Epub 2011 Jul 29. Review.

43.

Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance.

Samuelsen Ø, Toleman MA, Hasseltvedt V, Fuursted K, Leegaard TM, Walsh TR, Sundsfjord A, Giske CG.

Clin Microbiol Infect. 2011 Dec;17(12):1811-6. doi: 10.1111/j.1469-0691.2011.03532.x. Epub 2011 May 20.

44.

Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection.

Davey MS, Lin CY, Roberts GW, Heuston S, Brown AC, Chess JA, Toleman MA, Gahan CG, Hill C, Parish T, Williams JD, Davies SJ, Johnson DW, Topley N, Moser B, Eberl M.

PLoS Pathog. 2011 May;7(5):e1002040. doi: 10.1371/journal.ppat.1002040. Epub 2011 May 12.

45.

A promising target for treatment of multidrug-resistant bacterial infections.

Davey MS, Tyrrell JM, Howe RA, Walsh TR, Moser B, Toleman MA, Eberl M.

Antimicrob Agents Chemother. 2011 Jul;55(7):3635-6. doi: 10.1128/AAC.00382-11. Epub 2011 May 2. No abstract available.

46.

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.

Walsh TR, Weeks J, Livermore DM, Toleman MA.

Lancet Infect Dis. 2011 May;11(5):355-62. doi: 10.1016/S1473-3099(11)70059-7. Epub 2011 Apr 7.

PMID:
21478057
47.

Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?

Nordmann P, Poirel L, Toleman MA, Walsh TR.

J Antimicrob Chemother. 2011 Apr;66(4):689-92. doi: 10.1093/jac/dkq520. Epub 2011 Jan 28.

PMID:
21393184
48.

Balkan NDM-1: escape or transplant?

Livermore DM, Walsh TR, Toleman M, Woodford N.

Lancet Infect Dis. 2011 Mar;11(3):164. doi: 10.1016/S1473-3099(11)70048-2. No abstract available.

PMID:
21371654
49.

The new medical challenge: why NDM-1? Why Indian?

Walsh TR, Toleman MA.

Expert Rev Anti Infect Ther. 2011 Feb;9(2):137-41. doi: 10.1586/eri.10.159. No abstract available.

PMID:
21342058
50.

How to detect NDM-1 producers.

Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR.

J Clin Microbiol. 2011 Feb;49(2):718-21. doi: 10.1128/JCM.01773-10. Epub 2010 Dec 1. Review.

Supplemental Content

Loading ...
Support Center